Furthermore, administration of IL-33 to wild type mice significantly reduced the cytotoxic activities of NK cells but not CD8+ T cells, although mammary tumor progression was unaffected when CD8+ T cells were depleted in vivo [54]. This evidence concerns the gene IL33 and breast cancer.